Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesOther Gross PP&E AdjustmentsShares Issued
Ratios

Immunocore Holdings (IMCR) Accumulated Depreciation & Amortization (2021 - 2024)

Historic Accumulated Depreciation & Amortization for Immunocore Holdings (IMCR) over the last 4 years, with Q4 2024 value amounting to $4.2 million.

  • Immunocore Holdings' Accumulated Depreciation & Amortization rose 243.9% to $4.2 million in Q4 2024 from the same period last year, while for Dec 2024 it was $4.2 million, marking a year-over-year increase of 243.9%. This contributed to the annual value of $4.2 million for FY2024, which is 243.9% up from last year.
  • Latest data reveals that Immunocore Holdings reported Accumulated Depreciation & Amortization of $4.2 million as of Q4 2024, which was up 243.9% from $4.1 million recorded in Q4 2023.
  • Over the past 5 years, Immunocore Holdings' Accumulated Depreciation & Amortization peaked at $7.6 million during Q4 2021, and registered a low of $4.1 million during Q4 2023.
  • Moreover, its 4-year median value for Accumulated Depreciation & Amortization was $4.8 million (2022), whereas its average is $5.3 million.
  • In the last 5 years, Immunocore Holdings' Accumulated Depreciation & Amortization crashed by 3026.32% in 2022 and then soared by 243.9% in 2024.
  • Immunocore Holdings' Accumulated Depreciation & Amortization (Quarter) stood at $7.6 million in 2021, then plummeted by 30.26% to $5.3 million in 2022, then decreased by 22.64% to $4.1 million in 2023, then increased by 2.44% to $4.2 million in 2024.
  • Its last three reported values are $4.2 million in Q4 2024, $4.1 million for Q4 2023, and $5.3 million during Q4 2022.